DePuy Synthes, the orthopaedics business of Johnson & Johnson MedTech, is setting up a global capability centre in Bengaluru. The centre will be built in phases, with initial operations and recruitment starting in August 2026. The company expects to employ about 500 people there over the next 18 to 24 months, with room to grow further as the site matures.
DePuy Synthes sits inside the medical technology arm of Johnson & Johnson and focuses on orthopaedic care, covering products and services used by surgeons, hospitals and patients around the world. The Bengaluru centre is meant to become a global engine for innovation, engineering and enterprise services for the business, pulling technology, data and business capabilities into one hub that supports clinical innovation and day to day operations worldwide.
What the centre will do
At launch, the centre will take on software development, data and AI, enterprise applications, technology services and cybersecurity, among other work. Nicholas Parrotta, chief information officer of DePuy Synthes, will lead the centre. Jai Ganesh, the business’s chief technology officer, will oversee technology engineering, architecture, infrastructure, cybersecurity engineering and digital platforms. Nagaraj Bhat, named GCC leader, will help establish local operations and build the leadership team on the ground. Hiring is expected to favour people with software engineering backgrounds and experience in healthcare applications.
Why Bengaluru
Bengaluru offers the deepest pool of software, data and engineering talent in the country, along with mature infrastructure for running large technology operations. The city continues to draw fresh GCC commitments from multinational technology and life sciences firms, which gives a new medtech centre a ready supply of people who have already worked on regulated, global systems.
DePuy Synthes’s India footprint
The company has framed the investment as part of a long term commitment to India. Namal Nawana, worldwide president of DePuy Synthes, has described India as one of the fastest growing markets in the world for orthopaedic care. The new centre widens the offshore technology base of Johnson & Johnson MedTech in the country and gives the orthopaedics business a dedicated India hub of its own.
What it signals
Medical device makers have been slower than pharma and software firms to build large captive centres in India, so a 500 person commitment from a major orthopaedics business stands out. It reflects how much of medtech value now sits in software, data and cybersecurity rather than hardware alone, and it adds weight to Bengaluru’s standing as the default choice for healthcare technology work at global scale.
At a glance
- Home country: United States
- Sector: Healthcare and Life Sciences
- City: Bengaluru
- Date: August 2026
- Status: Announced
- Scale: About 500 people within 18 to 24 months, built in phases
Follow every new global capability centre in India on our India GCC Tracker.
